07.01.25 -- Closed-Loop Manufacturing Is The Cell Therapy Revolution We Need

Explore a scalable, sterile solution for isolating extracellular vesicles (EVs) in exosome therapeutics to enhance yield, purity, and commercial viability through innovative filtration technology.

Understand the critical considerations for implementing closed systems in bioproduction, from vessel selection to workflow customization for optimal efficiency and safety.

Implement strategies to reduce unplanned downtime and keep your biomanufacturing on track with a checklist and planning to enhance reliability and resilience.

Discover how N-1 perfusion and concentrated fed-batch can revolutionize biomanufacturing by exploring an advanced data analytics tool that simplifies early-stage upstream process optimization through in silico simulations.

Discover key strategies for controlling LNP formulation and upscaling. Explore the science behind lipid nanoparticles, critical parameters, and achieving effective turbulent mixing for optimal outcomes.

Is your sterility testing process hindering your product release? Discover how the right approach can streamline your process, reduce false positives, and ultimately save you time and money.

Explore insights from international experts on the rapidly growing CGT field. What are the challenges being faced? What trends are being seen? What are the future directions for cell and gene therapy?

Watch to learn about solutions to address challenges in standardizing flow cytometry and cell analysis solutions that support drug development at every stage.

How can you address the decontamination challenges associated with isolated fill-finish operations? New innovations are being implemented to ensure superior sporicidal reduction and operational safety.